搜尋結果
Rheumatology. Jaccoud arthropathy ( JA ), is a chronic non-erosive reversible joint disorder that may occur after repeated bouts of arthritis. [1] [2] It is caused by inflammation of the joint capsule and subsequent fibrotic retraction, causing ulnar deviation of the fingers, through metacarpophalangeal joint (MCP) subluxation, [1] [3 ...
Rheumatology. Psoriatic arthritis (PsA) is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis. [1] [2] The classic feature of psoriatic arthritis is swelling of entire fingers and toes with a sausage-like appearance ("sausage digit"). [3]
Sulfasalazine. Sulfasalazine, sold under the brand name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. [5] It is considered by some to be a first-line treatment in rheumatoid arthritis. [6] It is taken by mouth or can be administered rectally.
Rheumatoid neutrophilic dermatitis occurs more frequently in patients with severe, persistent seropositive arthritis; it presents clinically as erythematous papules, nodules, plaques, or lesions resembling urticaria without any accompanying symptoms. [3] [4] [5] Less common conditions include annular lesions, blisters, ulcers, and vesicles.
Sarah Hewlett. Sarah Elizabeth Hewlett OBE is an emeritus Professor of Rheumatology Nursing at the University of the West of England and expert on rheumatoid arthritis (RA). [1] [2] She was appointed an Officer of the Order of the British Empire in the 2019 Birthday Honours .
Moreover, similar conditions can also be seen in juvenile rheumatoid arthritis and psoriatic arthritis. Synovectomy for RA [2] has become relatively rare because nowadays patients with Rheumatoid Arthritis [3] have access to disease modifying drugs called biologics that are effective in containing the inflammation that damages the synovial tissue.
Methotrexate. Hydroxychloroquine. Auranofin, a gold salt. Disease-modifying antirheumatic drugs ( DMARDs) comprise a category of otherwise unrelated disease-modifying drugs defined by their use in rheumatoid arthritis to slow down disease progression. [1] [2] The term is often used in contrast to nonsteroidal anti-inflammatory drugs (which ...
